---
$id: https://graph.org.ai/products/commodity/51171854
$type: Product
source: UNSPSC
code: "51171854"
title: "Ramosetron"
class: "51171800"
classTitle: "Antiemetics and antinauseants and antivertigo agents"
family: "51170000"
familyTitle: "Drugs affecting the gastrointestinal system"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Ramosetron

**UNSPSC Code**: 51171854
**Class**: [Antiemetics and antinauseants and antivertigo agents](Antiemetics and antinauseants and antivertigo agents.mdx)
**Family**: [Drugs affecting the gastrointestinal system](../Drugs affecting the gastrointestinal system.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a 5-ht3 receptor antagonist and antiemetic agent with the molecular formula C17H17N3O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7ZRO0SC54Y, chemically known as (-)-(r)-1-methylindol-3-yl-4,5,6,7-tetrahydro-5-benzimidazolyl ketone. but generally known as ramosetron, which bears US NIH Compound Identifier 108000. European Medicines Agency schedules Ramosetron in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10254MIG. The term RAMOSETRON is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 8 No. 3 1994, List 34). RAMOSETRON is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule ramosetron under HS 29339990 and SITC 51577. As of Q4 2014, RAMOSETRON remains the US FDA Preferred Term for this commodity. Ramosetron bears US NLM identifiers UMLS ID C0526950 and NCI Concept Code C61921. SMILES: O=C(C1CCC2NC[NH]C2C1)C1C2C(N(C1)C)CCCC2.

